Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. (ticker: PWUP) is a biopharma-focused special purpose acquisition company that filed a Form 10-Q with the SEC on August 16, 2024, covering its most recent fiscal quarter. Operating within the life sciences and biopharmaceutical sector, PWUP remains an active registrant as of its most recent quarterly disclosure, filed under accession number 0001493152-24-032815. The company's focus on biopharma targets reflects continued SPAC activity in the healthcare space during the 2024 filing period. For the full data profile on PWUP — including sponsor details, deal timeline, financials, and SEC filings — sign up for SpacDesk at spacdesk.com.